ALXN

Alexion Pharmaceuticals, Inc. News Headlines

$166.06
*  
1.14
0.68%
Get ALXN Alerts
*Delayed - data as of Oct. 2, 2014 12:22 ET  -  Find a broker to begin trading ALXN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ALXN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Proshares UltraPro QQQ Experiences Big Inflow
10/2/2014 11:02:47 AM - BNK Invest

Insider Buys And Sells: American Eagle Outfitters, Facebook
9/28/2014 10:50:00 AM - Seeking Alpha

Stocks Move Mostly Higher As Traders Hunt For Bargains - U.S. Commentary
9/24/2014 12:14:00 PM - RTT News

Biotech Stock Roundup: Auxilium an Acquisition Target, Amgen Submits another BLA - Analyst Blog
9/24/2014 11:05:00 AM - Zacks.com

Is Illumina (ILMN) Worth Adding to Your Portfolio? - Analyst Blog
9/22/2014 3:20:00 PM - Zacks.com

Noteworthy ETF Inflows: TQQQ, ATVI, AKAM, ALXN
9/18/2014 10:54:50 AM - BNK Invest

3 Hot Ways to Play the Biotechnology Bonanza
9/17/2014 10:52:17 AM - InvestorPlace Media

Alexion Names David Hallal COO - Quick Facts
9/17/2014 7:53:00 AM - RTT News

If Achillion's Hep C Nucleotide Isn't Best In Class, The Stock Is Worth Low Single Digits
9/16/2014 8:00:00 AM - Seeking Alpha

Is Intercept Pharmaceuticals Building The Next Great Specialty Franchise?
9/15/2014 2:30:00 PM - Seeking Alpha

Alexion Reports Improved Survival With Asfotase Alfa In HPP Children
9/15/2014 1:01:00 AM - RTT News

Alexion's Asfotase Alfa Gets Japanese Orphan Drug Status - Analyst Blog
9/9/2014 5:30:00 PM - Zacks.com

Alexion Pharma To Present At Robert W. Baird Conference; Webcast At 1:25 PM ET
9/8/2014 12:25:00 PM - RTT News

Alexion Pharma: Asfotase Alfa Granted Orphan Drug Designation In Japan
9/8/2014 6:35:00 AM - RTT News

Alexion Pharmaceuticals' Soliris Wins NICE Backing for aHUS - Analyst Blog
9/4/2014 5:00:00 PM - Zacks.com

IBB, CELG, BIIB, ALXN: ETF Outflow Alert
9/2/2014 11:18:23 AM - BNK Invest

Pfizer's C. Difficile Vaccine Gets Fast Track Status - Analyst Blog
8/29/2014 6:10:00 PM - Zacks.com

Isis Pharmaceuticals Starts Phase III Study on ISIS-APOCIIIRx - Analyst Blog
8/29/2014 4:55:00 PM - Zacks.com

Repros Reports Encouraging Late-Stage Data on Androxal - Analyst Blog
8/28/2014 4:30:00 PM - Zacks.com

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog
8/27/2014 10:32:00 AM - Zacks.com

Alexion Initiates Registration Trial Of Eculizumab To Prevent DGF
8/25/2014 6:54:00 AM - RTT News

Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2014 Update
8/23/2014 10:34:00 AM - Seeking Alpha

Cramer's Mad Money - 12 Stocks That Have Performed Better Than Google (8/21/14)
8/22/2014 6:22:00 AM - Seeking Alpha

Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus - Analyst Blog
8/20/2014 11:08:00 AM - Zacks.com

Amgen (AMGN) Reports Encouraging Top-Line Data on AMG 416 - Analyst Blog
8/19/2014 5:25:00 PM - Zacks.com